Kaohsiung, Taiwan

Wei-Yi Sung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Kaohsiung University of Applied Sciences. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Yi Sung. Retrieved from https://idiyas.com/inventor/wei-yi-sung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wei-Yi Sung in Cancer Cell Testing

Introduction

Wei-Yi Sung is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of cancer research through his innovative methods. His work focuses on improving the testing and understanding of cancer cell stages, which is crucial for effective treatment.

Latest Patents

Wei-Yi Sung holds a patent for a "Light-trapping cancer cell stage testing method." This method involves measuring the escape velocities of different cancer cells to determine their stages. By comparing the escape velocities of stage-unknown cancer cells with reference ratios stored in a database, this method provides a reliable way to assess cancer progression.

Career Highlights

Wei-Yi Sung is affiliated with the National Kaohsiung University of Applied Sciences. His role at the university allows him to engage in research and development, contributing to advancements in medical technology. His innovative approach has garnered attention in the scientific community.

Collaborations

Wei-Yi Sung has collaborated with colleagues such as Shih-Kun Liu and Li-Chin Chen. These partnerships enhance the research efforts and broaden the impact of their findings in the field of cancer research.

Conclusion

Wei-Yi Sung's contributions to cancer cell testing represent a significant advancement in medical technology. His innovative methods have the potential to improve cancer diagnosis and treatment, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…